Price History

Hover for the daily close. The dotted line marks the period open.

Compare OM with… →

OM Key Statistics

As of Sep 4, 2026

Trading

Open: $3.57
Previous Close: $3.57
Day's Range: 3.53–3.65
52-Week Range: 3.00–16.16
Volume: 82.20K
Beta: 1.90

Valuation

Market Cap: $67.48M
P/E Ratio: unprofitable
P/S ratio: 0.57
EPS (ttm): −3.80

Financials (FY)

Revenue (FY): $119.48M+5.09%
Net Income (FY): −$81.65M
Profit margin: −63.06%
Shares Outstanding: 18.80M
1-Year Return: −73.11%

Dividend and dates

Earnings Date: November 9, 2026estimated
Avg Volume: 195.69K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

OM Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

−6.33%−18.91%−43.98%−79.05%−79.48%−77.72%−3.23%

2020*202120222023202420252026*

Year	Return
2026 (partial year)	−3.23%
2025	−77.72%
2024	−79.48%
2023	−79.05%
2022	−43.98%
2021	−18.91%
2020 (partial year)	−6.33%

As of September 4, 2026.

OM Revenue and Earnings by Fiscal Year

FY ends December

RevenueNet income

2022202320242025

Fiscal year	Revenue	Net income	Net margin
2025	$119.48M	−$81.65M	−68.3%
2024	$113.69M	−$127.98M	−112.6%
2023	$130.38M	−$172.80M	−132.5%
2022	$115.38M	−$162.96M	−141.2%

Fiscal year	Revenue	Gross profit	Operating income	Net income	Net margin
2025	$119.48M	$46.75M	−$66.71M	−$81.65M	−68.3%
2024	$113.69M	$38.56M	−$113.38M	−$127.98M	−112.6%
2023	$130.38M	$29.00M	−$169.77M	−$172.80M	−132.5%
2022	$115.38M	$17.83M	−$161.02M	−$162.96M	−141.2%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

OM Valuation vs Medical Devices Median

Median of 151 stocks

Metric	OM	Medical Devices median	vs median
P/S ratio	0.57	2.98	0.2x the median
Profit margin	−63.06%	−1.69%	61.4 pts below

Medians across 151 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Outset Medical, Inc. (OM) carries a market capitalisation of $67.48M. It is classified in the Medical Devices industry, within the Healthcare sector. The company reports 310 employees.

OM last closed at $3.59 on September 4, 2026. That is +$0.02 (+0.70%) against the previous close. Over the past 52 weeks the price has ranged from $3.00 to $16.16. The latest close sits 19.67% above that 52-week low.

Financial Health

In fiscal 2025, Outset Medical, Inc. reported revenue of $119.48M. Against the prior fiscal year total of $113.69M, that is a change of +5.09%. The same year closed with a net loss of $81.65M. Profit margin runs at −63.06%. That is 61.4 percentage points below the Medical Devices median of −1.69%. Earnings per share on a trailing basis come to −3.8.

Across the 4 fiscal years on file, revenue moves from $115.38M in 2022 to $119.48M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. The price-to-sales ratio is 0.57. On price-to-sales that is 0.2 times the Medical Devices median of 2.98. 151 Medical Devices companies report these metrics, and the medians quoted come from that group.

Over the trailing twelve months the price has returned −73.11%. Measured over 5 years, that is −65.58% a year compounded. The reported beta is 1.9. Annualized volatility over the trailing 6 years is 95.45%.

Growth & Income

The record shows no dividend for OM.

The strongest complete calendar year on file is 2021 at −18.91%; the weakest is 2024 at −79.48%. Of the 5 complete calendar years on file, 0 finished higher. So far in 2026 the price is −3.23%.

Peer Comparison

Outset Medical, Inc. (OM) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company	Ticker	Market Cap	P/E Ratio
Outset Medical, Inc.	OM	$67.48M	—
Abbott Laboratories	ABT	$187.45B	35.1
Medtronic plc.	MDT	$120.46B	22.9
Stryker Corporation	SYK	$116.27B	31.9

The Medical Devices industry average P/E ratio is 26.8x. Outset Medical, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$187.45B

MDT

Medtronic plc.

$120.46B

SYK

Stryker Corporation

$116.27B

BSX

Boston Scientific Corporation

$69.27B

EW

Edwards Lifesciences Corporation

$51.82B

DXCM

DexCom, Inc.

$33.17B

View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

JNJ

Johnson & Johnson

$663.28B

ABBV

AbbVie Inc.

$453.19B

MRK

Merck & Co., Inc.

$370.89B

UNH

UnitedHealth Group Incorporated

$356.47B

View all Healthcare stocks →

About Outset Medical, Inc.

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also offers Tablo Data Ecosystem, including TabloHub, a consumer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Visit website →

Outset Medical, Inc. (OM) Stock Analysis